Venture Fund Member Profile
|
 |
 |
Compass Venture is a venture capital firm focused on investing in emerging companies, with high-growth potential and a focus on science and technology, innovation and intellectual property. We are experienced as technology investors and managers. Our mission is to enable and support entrepreneurs grow sustainable businesses with large market potentials. We do so with capital, the collective experience of our partners and the access to our network of relationships. We believe we are ideally suited to participate in and help lead the continued development of important innovative, early-stage companies. We invest in both the developers of new technologies and those making innovative applications of existing technologies.
|
David Arscott Managing Director Compass Technology Partners |
David has spent his entire professional career investing in private and public technology companies. In 1968, he joined the group which became Citicorp Venture Capital Limited (“CVC”) in New York. He established CVC's West Coast Office in 1973 which served as the focus of CVC's investing activities in the western United States for over 15 years. In 1978, he left to co-found Arscott, Norton & Associates (“ANA”), which formed three venture capital funds whose $75 million in capital funded 36 high-technology companies, including Iomega, Lam Research and Dallas Semiconductor. In 1988, David formed Compass Management Partners (“CMP”), which in turn organized Compass Technology Partners and Compass Technology Group. David’s formative premise for Compass is that information garnered in the venture capital investment process has direct applicability in the selection of high-potential publicly-traded investments.
Representative Investments
 |
Oculex Pharmaceuticals Oculex Pharmaceuticals is a drug delivery and specialty pharmaceutical company. The company has a novel, patented delivery systems that permit drugs to be delivered within the eye for the treatment of major eye diseases, many of which were previously untreatable. The biodegradable BDD™ drug delivery technology is the first biodegradable, controlled release, intraocular drug delivery platform, designed to deliver a range of drug products, with programmability for up to one year. The delivery system then dissolves so the implant does not need to be removed. Oculex was purchased by Allergan in 2003
www.allergan.com |
 |
Photodigm Photodigm is focused on the integration of photonics at the wafer level. Photodigm is developing state-of-the-art optoelectronic components for next generation telecom and datacom systems, long wavelengths telecom lasers (1.33nm and 1.55nm). With its unique semiconductor laser architecture, Photodigm's technology promises major improvements in the cost and performance of photonics devices. This technology represents a potential breakthrough in the architecture and the manufacturing of these long wavelength lasers, resulting in much lower costs and higher yields in production.
www.Photodigm.com
|
 |
Boxer Cross Boxer Cross designs and manufactures a non-contact metrology tool used in the manufacture of advanced semiconductor devices. The technology is laser-based and the two main applications focus on ion implant monitoring and the entire copper interconnect process, critical to semiconductor device fabrication at geometries <0.13 mm. Boxer Cross was acquired by Applied Materials in 2003
www.appliedmaterials.com
|
 |
Ripfire Ripfire provides comprehensive information retrieval solutions . The company’s proprietary search engine set a new standard for search and navigation of structured and unstructured information. Ripfire was acquired by Plumtree Software in 2001.
www.Ripfire.com
|
David participated in the FundingPost event: Early-Stage and Seed VC Breakfast
on Tuesday, June 27, 2006 in CA, Sponsored by Orrick, The City of Menlo Park
To list your Company on our website and make your profile available to David and 7,500+ other VCs and Angel Investors, Click Here.
============================================
About FundingPost
For almost nine years FundingPost has worked with thousands
of Angel and Venture Capital Investors. We believe that it is
important to reach investors in every medium possible -
both online and offline. We have been directly responsible for
tons of success stories and Millions and Millions of dollars raised.
We look forward to introducing your company to the leading Venture and Angel Investors nationwide.
============================================
|
| Venture Fund Member Profile |
|